First, we analyzed ADAMTS12 levels in 382 cervical cancer patients and found that ADAMTS12 levels were higher in tumors with a higher degree of malignancy, including patients with high FIGO stage, poorly differentiated status, and pathological type of non-squamous cell carcinoma. This evidence concerns the gene ADAMTS12 and squamous cell carcinoma.